Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
(Q51982870)
scientific article published in May 2006
scientific article published in May 2006
Language:
other details
description | scientific article published in May 2006 |
External Links
(P356) |
10.1158/0008-5472.CAN-05-3396
|
(P698) |
16651452
|